The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Information About a Doctor or a Possibility of Choosing Doctor's Gender and Attendance to Screening Colonoscopy
Official Title: Is the Information About a Doctor or Possibility of Choosing Doctor's Gender Associated With Attendance to Screening Colonoscopy: Randomized Study With Three Types of Invitations.
Study ID: NCT01182922
Brief Summary: The purpose of the study is to investigate whether the information about a doctor or possibility to choose doctor's gender included in invitation letter is associated with attendance rate to screening colonoscopy.
Detailed Description: Study is performed as a part of NordICC (Clinical trials NCT 00883792) trial, which is intended to investigate the effect of screening colonoscopy on colorectal cancer incidence and mortality. NordICC trial is a multicenter, randomized study conducted in Norway, Sweden, Netherlands and Poland. This study is designed to assess two factors potentially influencing patients attendance. These two factors are: identification of particular doctor performing examination and the possibility of choosing doctor's gender.
Minimum Age: 55 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: No
The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,, Warsaw, , Poland
Name: Jaroslaw Regula, MD, PhD
Affiliation: Center of Oncology Institute
Role: STUDY_DIRECTOR
Name: Krzysztof Skoczylas, MD
Affiliation: Center of Oncology Institute
Role: PRINCIPAL_INVESTIGATOR
Name: Michal F Kaminski, MD
Affiliation: Center of Oncology Institute
Role: STUDY_CHAIR